SWOG clinical trial number
SWOG-9218

Measurement of Biologic and Molecular Tumor Markers in Patients with High Grade Primary Brain Tumors Treated on SWOG-8737

Closed
Phase
Published
Abbreviated Title
Ancillary
Activated
01/15/1993
Closed
04/01/2002
Participants
NCORP, Members, Medical Oncologists, Pathologists

Research committees

Brain Cancer

Eligibility Criteria Expand/Collapse

Measurement of biologic and molecular tumor markers in patients with high grade primary brain tumors treated on SWOG-8737.

Publication Information Expand/Collapse

1998

Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival for malignant astrocytoma patients treated with bis-chloroethylnitrosourea: A Southwest Oncology Group study.

KA Jaeckle;HJ Eyre;JJ Townsend;S Schulman;HM Knudson;M Belanich;DB Yarosh;SI Bearman;DJ Giroux;SC Schold Journal of Clinical Oncology 16(10):3310-3315

1996

Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated wtih carmustine.

M Belanich;M Pastor;T Randall;D Guerra;J Kibitel;L Alas;B Li;M Citron;P Wasserman;A White;H Eyre;K Jaeckle;S Schulman;D Rector;M Prados;S Coons;W Shapiro;D Yarosh Cancer Research 56(4):783-788